Artivion (AORT): Chief Commercial Officer sold ~$65K
John E Davis, Chief Commercial Officer at Artivion, sold ~$65K of Artivion shares.
- ~$65K
- Approx. value · 2,618 sh @ $24.80
- 208K
- Holds after · shares reported
- Traded
- Mar 6, 2025
- Filed
- Mar 10, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 24, 2025Insider · 6 peopleInsiders: 21 sales (~$1.8M)
- Mar 5, 2025Insider · 2 peopleInsiders: 2 purchases (~$53K), 1 sale (~$12K)
- Mar 6, 2025 · this disclosureInsiderOfficer sold ~$65K of AORT shares in the open market
What came next
- Mar 6, 2025Insider · 5 peopleInsiders: 6 sales (~$2.4M)
- Mar 11, 2025Insider · 2 peopleInsiders: 2 sales (~$782K)
- May 9, 2025Insider · 1 personInsiders: 2 sales (~$307K)
- May 21, 2025InsiderOfficer sold ~$288K of AORT shares in the open market
- May 23, 2025InsiderDirector sold ~$74K of AORT shares in the open market
- May 27, 2025InsiderOfficer sold ~$254K of AORT shares in the open market
- Jun 13, 2025Insider · 1 personInsiders: 4 sales (~$743K)
- Jun 17, 2025Insider · 1 personInsiders: 2 sales (~$443K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Artivion
For Artivion, OQRO holds 2 Congress trade reports and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AORT page.
Other recent filings by John E Davis, Chief Commercial Officer
- SEC Form 4 at Artivion (AORT)Aug 14, 2025
- SEC Form 4 at Artivion (AORT)Mar 12, 2025
- SEC Form 4 at Artivion (AORT)Feb 26, 2025
- SEC Form 4 at Artivion (AORT)Feb 26, 2025
- SEC Form 4 at Artivion (AORT)Feb 26, 2025
The full history of John E Davis, Chief Commercial Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which Artivion (AORT) insider traded, and how much?
John E Davis, Chief Commercial Officer at Artivion, sold ~$65K of Artivion shares. 2,618 shares at $24.80.
When did it happen, and when was it made public?
Traded: Mar 6, 2025. Filed: Mar 10, 2025. That is 4 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Artivion recently?
For Artivion, OQRO holds 2 Congress trade reports and 2 federal contract awards dated in the last 90 days. They are listed on the AORT page.
Does this mean AORT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Artivion
- USAspending.gov award recordSep 29, 2026
- House Clerk periodic transaction reportSep 10, 2026
- House Clerk periodic transaction reportSep 4, 2026
- USAspending.gov award recordAug 26, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRJul 24, 2026
Everything OQRO holds on this company is on its AORT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
